Incretin analogues that have been developed to treat type 2 diabetes hold promise as a novel treatment strategy for Alzheimer's disease.
Holscher
Christian
C
School of Biomedical Sciences, Ulster University, Cromore road, Coleraine BT52 1SA, UK. c.holscher@ulster.ac.uk